Header Logo

LINEO THAHANE

Concepts (80)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
HIV Infections
11
2026
2037
0.830
 Why?
Anti-HIV Agents
6
2026
359
0.730
 Why?
Viremia
3
2026
132
0.480
 Why?
Drug Resistance, Viral
3
2026
56
0.450
 Why?
Global Health
4
2025
632
0.440
 Why?
Child Health
2
2025
66
0.370
 Why?
Tuberculosis, Pulmonary
2
2023
237
0.300
 Why?
Lesotho
7
2026
18
0.290
 Why?
Piperazines
2
2026
272
0.260
 Why?
Lopinavir
1
2026
9
0.240
 Why?
HIV Integrase Inhibitors
1
2026
15
0.240
 Why?
Tanzania
5
2026
68
0.240
 Why?
Heterocyclic Compounds, 3-Ring
1
2026
46
0.230
 Why?
Pediatrics
2
2025
1230
0.210
 Why?
HIV-1
2
2026
477
0.200
 Why?
HIV
2
2023
179
0.200
 Why?
Garbage
1
2022
1
0.190
 Why?
Capacity Building
1
2021
26
0.180
 Why?
Hospital Medicine
1
2021
33
0.170
 Why?
Culturally Competent Care
1
2021
50
0.170
 Why?
Evidence-Based Practice
1
2021
116
0.160
 Why?
Child
14
2026
26239
0.150
 Why?
Adolescent
11
2026
20917
0.140
 Why?
Viral Load
3
2026
406
0.140
 Why?
Anti-Retroviral Agents
2
2023
153
0.130
 Why?
Betacoronavirus
1
2020
287
0.130
 Why?
Poverty
1
2020
455
0.120
 Why?
Hospitals, Pediatric
1
2021
794
0.120
 Why?
Delivery of Health Care
1
2021
682
0.110
 Why?
Internship and Residency
1
2025
1213
0.110
 Why?
Coronavirus Infections
1
2020
366
0.110
 Why?
Pneumonia, Viral
1
2020
378
0.110
 Why?
Pyridones
2
2026
148
0.110
 Why?
Child, Preschool
8
2026
15047
0.110
 Why?
Practice Guidelines as Topic
1
2021
1305
0.110
 Why?
Tuberculosis
1
2020
553
0.110
 Why?
Infant
7
2026
13300
0.100
 Why?
Pandemics
1
2020
1160
0.090
 Why?
Africa South of the Sahara
2
2024
120
0.090
 Why?
Humans
16
2026
131504
0.080
 Why?
Antiretroviral Therapy, Highly Active
1
2010
260
0.070
 Why?
Male
9
2026
65158
0.070
 Why?
Qualitative Research
2
2022
703
0.070
 Why?
Female
9
2026
71087
0.070
 Why?
CD4 Lymphocyte Count
2
2022
228
0.070
 Why?
Genotype
2
2026
2655
0.070
 Why?
Young Adult
3
2026
10092
0.060
 Why?
Malawi
2
2021
339
0.060
 Why?
Oxazines
1
2026
33
0.060
 Why?
Patient Satisfaction
1
2026
458
0.050
 Why?
Infant, Newborn
3
2024
8589
0.050
 Why?
Group Processes
1
2022
48
0.050
 Why?
Treatment Outcome
3
2026
12936
0.040
 Why?
Income
1
2022
135
0.040
 Why?
World Health Organization
1
2021
115
0.040
 Why?
Botswana
1
2021
75
0.040
 Why?
Herpes Genitalis
1
2020
10
0.040
 Why?
International Cooperation
1
2021
161
0.040
 Why?
Uganda
1
2021
94
0.040
 Why?
Growth Disorders
1
2022
184
0.040
 Why?
Africa
1
2021
141
0.040
 Why?
Retrospective Studies
3
2024
17648
0.040
 Why?
Curriculum
1
2025
782
0.040
 Why?
Treatment Failure
1
2020
353
0.040
 Why?
Proportional Hazards Models
1
2023
1405
0.040
 Why?
Counseling
1
2020
237
0.040
 Why?
Cost-Benefit Analysis
1
2020
543
0.030
 Why?
Developing Countries
1
2020
303
0.030
 Why?
Longitudinal Studies
1
2020
1516
0.030
 Why?
Surveys and Questionnaires
1
2025
4037
0.030
 Why?
Prospective Studies
1
2026
6485
0.030
 Why?
Mass Screening
1
2021
825
0.030
 Why?
Cohort Studies
1
2022
5120
0.020
 Why?
Mutation
1
2026
6177
0.020
 Why?
Nutritional Status
1
2012
302
0.020
 Why?
Adult
2
2022
31666
0.020
 Why?
Child Mortality
1
2010
23
0.020
 Why?
Program Evaluation
1
2010
441
0.020
 Why?
Cause of Death
1
2010
510
0.020
 Why?
Risk Factors
1
2020
10952
0.010
 Why?
THAHANE's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (80)
Explore
_
Co-Authors (18)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_